Lifecore Biomedical, Inc. Common Stock (LFCR) Stock Price

LFCRStock

$4.54−40.42%52W

Market Cap$171.85M

P/E—

PEG Ratio2.66

Div yield—

Beta1.08

LFCR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-49.05%

Price vs S&P 500 (4W)1.88%

PEG Ratio2.66

VGM Score38.77

P/CF (Annual)24.63x

Book Value / Share (Quarterly)$0.43

P/TBV (Annual)5.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-9.91%

Cash Flow / Share (Quarterly)$0.12

Price vs S&P 500 (YTD)-57.32%

Gross Margin (TTM)29.28%

Net Profit Margin (TTM)-29.93%

EPS (TTM)$-1.31

10-Day Avg Trading Volume0.11M

EPS Excl Extra (TTM)$-1.31

Revenue Growth (5Y)-15.13%

EPS (Annual)$-0.48

ROI (Annual)-10.19%

Gross Margin (Annual)31.37%

Net Profit Margin (5Y Avg)-40.52%

Cash / Share (Quarterly)$0.46

Revenue Growth QoQ (YoY)-6.25%

ROA (Last FY)-7.74%

Revenue Growth TTM (YoY)27.26%

EBITD / Share (TTM)$0.12

ROE (5Y Avg)-104.45%

Operating Margin (TTM)-3.60%

Cash Flow / Share (Annual)$0.10

P/B Ratio11.22x

P/B Ratio (Quarterly)12.24x

Net Income / Employee (Annual)$-47,000

EV / Revenue (TTM)1.94x

Net Interest Coverage (TTM)-0.13x

ROA (TTM)-21.29%

EV / EBITDA (TTM)71.37x

EPS Incl Extra (Annual)$-0.48

Current Ratio (Annual)3.49x

Quick Ratio (Quarterly)2.55x

3-Month Avg Trading Volume0.18M

52-Week Price Return-40.42%

EV / Free Cash Flow (Annual)87.61x

Revenue / Employee (TTM)$429,300

Tangible BV / Share (Quarterly)$0.87

P/S Ratio (Annual)2.39x

Asset Turnover (Annual)0.33x

52-Week High$8.98

Operating Margin (5Y Avg)-19.38%

EPS Excl Extra (Annual)$-0.48

CapEx CAGR (5Y)-31.08%

Tangible BV CAGR (5Y)-35.73%

26-Week Price Return-37.12%

Quick Ratio (Annual)2.18x

13-Week Price Return-8.65%

Total Debt / Equity (Annual)4.18x

Current Ratio (Quarterly)3.87x

Enterprise Value$318.39M

Revenue / Share Growth (5Y)-19.16%

Asset Turnover (TTM)0.71x

Book Value / Share Growth (5Y)-32.61%

Revenue / Employee (Annual)$197,700

Inventory Turnover (Annual)2.45x

Pretax Margin (Annual)-23.34%

Cash / Share (Annual)$0.47

3-Month Return Std Dev53.92%

Gross Margin (5Y Avg)29.90%

Net Income / Employee (TTM)$-128,500

EBITDA CAGR (5Y)-23.76%

EBITDA Interim CAGR (5Y)-6.63%

ROE (Last FY)-52.73%

Net Interest Coverage (Annual)-0.32x

EPS Basic Excl Extra (Annual)$-0.48

P/FCF (TTM)17.25x

Receivables Turnover (TTM)4.45x

EV / Free Cash Flow (TTM)70.53x

Total Debt / Equity (Quarterly)9.64x

EPS Incl Extra (TTM)$-1.31

Receivables Turnover (Annual)3.86x

ROI (TTM)-28.47%

P/S Ratio (TTM)1.10x

Pretax Margin (5Y Avg)-29.05%

Revenue / Share (Annual)$2.02

Tangible BV / Share (Annual)$1.17

Price vs S&P 500 (52W)-58.98%

Year-to-Date Return-44.50%

5-Day Price Return-0.22%

EPS Normalized (Annual)$-0.48

ROA (5Y Avg)-19.95%

Net Profit Margin (Annual)-23.78%

Month-to-Date Return2.71%

Cash Flow / Share (TTM)$-1.85

EBITD / Share (Annual)$0.13

Operating Margin (Annual)-0.97%

LT Debt / Equity (Annual)3.98x

P/CF (TTM)18.35x

ROI (5Y Avg)-29.14%

LT Debt / Equity (Quarterly)9.23x

EPS Basic Excl Extra (TTM)$-1.31

P/TBV (Quarterly)8.46x

P/B Ratio (Annual)9.00x

Inventory Turnover (TTM)4.02x

Pretax Margin (TTM)-29.48%

Book Value / Share (Annual)$0.91

Price vs S&P 500 (13W)-10.61%

Beta1.08x

P/FCF (Annual)49.69x

Revenue / Share (TTM)$4.36

ROE (TTM)-182.29%

52-Week Low$3.63

vGradeC

gGradeD

mGradeD

vgmGradeD

LFCR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	-$0.22	-$0.19	+14.61%(+$0.03)
Q1 2026	May 6, 2026	-$0.29	-$0.43	-48.28%(-$0.14)
Q4 2025	Mar 16, 2026	-$0.16	-$0.16	+0.00%(+$0.00)
Q1 2025	Apr 3, 2025	-$0.15	-$0.47	-213.33%(-$0.32)
Q4 2024	Jan 2, 2025	-$0.29	-$0.25	+13.79%(+$0.04)

LFCR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.09

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
LFCRLifecore Biomedical, Inc. Common Stock	C	D	D	$4.54
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Lifecore Biomedical, Inc. Common Stock

Lifecore Biomedical is a fully integrated CDMO providing development, manufacturing, and fill-finish services for complex sterile injectable pharmaceuticals. The company serves multiple delivery formats—syringes, vials, and cartridges—and operates two business segments: contract development and manufacturing services, and hyaluronic acid manufacturing.